Executive summary Women's reproductive, maternal, newborn, child, and adolescent health
(RMNCAH) is a cornerstone for the healthy development of the next generation and a …

Chemotherapy and radiotherapy improved survival rates of patients with cancer. However,
they can cause ovarian failure and infertility in women of reproductive age. Infertility …

Endometriosis is a chronic, universal, and prevalent disease estimated to affect up to 1: 10
women of reproductive age. Endometriosis-associated ovarian cancer (EAOC) developing …

Purpose Ovarian cancer is the third most common gynaecological cancer among women,
yet remains under-researched. Past studies suggest that women who present with ovarian …

Ovarian cancer is more frequent in post-menopausal women, however it can also occur in
young premenopausal women. After diagnosis and cancer staging, health care providers …

Rising global infertility rates have amplified the dependence on assisted reproductive
technologies (ARTs) for conception. This necessitates a thorough examination of fertility …

Developments in chemotherapeutics have enhanced the survival rate of cancer patients,
however, adverse effects of chemotherapeutics on ovarian functions causes the fertility loss …

Background Ovarian cancer is the eighth most common cancer among women and due to
late detection prognosis is poor with an overall 5-year survival of 30–50%. Novel biomarkers …

Aim Epithelial ovarian cancer (EOC) can be a devastating diagnosis in women of
reproductive age who desire future fertility. However, in early‐stage disease, fertility‐sparing …

Endometriosis-associated ovarian cancer (EAOC) is an evolving distinct clinical entity and
challenge considered to develop from endometrioma (1). Several systematic reviews and …